Boardroom Alpha
Boardroom Alpha
DIT · Current Report (Form 8-K) · Filed December 18, 2025

Amcon Distributing Co — Current Report (Form 8-K)

Form
8-K
Filed
December 18, 2025
Period
Dec 18, 2025
Ticker
DIT
Accession
0001104659-25-122557
Boardroom Alpha · Filing insights

Six directors elected; board declared a $0.28 per share special dividend payable January 30, 2026.

About Amcon Distributing Co
Market cap
$79M
1Y TSR
−20.2%
3Y TSR
−24.7%
Board grade
A
Sector
Consumer Defensive
CEO
Christopher H Atayan
Last annual meeting: Dec 18, 2025 · View full Amcon Distributing Co profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Act of 1934

 

Date of Report (Date of earliest event reported) December 18, 2025

 

AMCON DISTRIBUTING COMPANY

(Exact name of registrant as specified in its charter)

 

Delaware   1-15589   47-0702918
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

  7405 Irvington Road, Omaha NE 68122  

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: 402-331-3727

 

  Not Applicable  

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFO 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value DIT NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The Company held its Annual Meeting on Thursday, December 18, 2025, at which Annual Meeting the Company’s stockholders voted upon the following matters:

 

·The election of six members of the Company’s board of directors.

 

·The ratification and approval of the selection of RSM US LLP as the Company’s independent registered public accounting firm for the Company’s 2026 fiscal year.

 

·The advisory approval of the compensation of the Company’s executives disclosed in the proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission.

 

·An advisory vote on whether future advisory votes on executive officer compensation should occur every 3 years, every 2 years or every 1 year.

 

Election of Directors

 

At the Annual Meeting, Christopher H. Atayan, Jeremy W. Hobbs, John R. Loyack, Stanley Mayer, Timothy R. Pestotnik and Andrew C. Plummer each was elected as a director. The following is a summary of the votes cast at the Annual Meeting with respect to the election of directors:

 

Name  Votes in Favor   Votes Withheld 
Christopher H. Atayan   572,051    5,675 
Jeremy W. Hobbs   575,612    2,114 
John R. Loyack   572,059    5,667 
Stanley Mayer   572,142    5,584 
Timothy R. Pestotnik   550,264    27,462 
Andrew C. Plummer   574,919    2,807 

 

There were 37,528 broker non-votes with respect to this matter.

 

Ratification and Approval of Independent Registered Public Accounting Firm

 

At the Annual Meeting, the selection of RSM US LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year was ratified and approved. The following is a summary of the votes cast at the Annual Meeting with respect to this matter:

 

   Votes in Favor   Votes Against   Votes Abstaining 
Ratification and approval of the selection of RSM US LLP   610,482    3,081    1,691 

 

There were no broker non-votes with respect to this matter.

 

 

 

 

Advisory Approval of Executive Compensation

 

At the Annual Meeting, stockholders provided advisory approval of the compensation of our executives disclosed in the proxy statement for the Annual Meeting pursuant to the compensation disclosure rules of the Securities and Exchange Commission. The following is a summary of the votes cast at the Annual Meeting with respect to this matter:

 

   Votes in
Favor
   Votes
Against
   Votes
Abstaining
 
Advisory approval of executive compensation   530,864    29,543    17,319 

 

There were 37,528 broker non-votes with respect to this matter.

 

Frequency of Executive Compensation Votes

 

At the Annual Meeting, stockholders provided advisory approval for holding future advisory votes on executive compensation every 3 years. The following is a summary of the votes cast at the annual meeting with respect to this matter:

 

   Votes for
3 Years
   Votes for
2 Years
   Votes for
1 Year
   Votes
Abstaining
 
Frequency of executive compensation votes   540,869    1,078    35,505    274 

 

There were 37,528 broker non-votes with respect to this matter.

 

The Company’s board of directors has determined that the Company will continue to submit the advisory vote to approve the compensation of the Company’s executives to stockholders every 3 years.

 

Item 8.01Other Events.

 

On December 18, 2025, the Company's board of directors declared a special cash dividend of $0.28 per common share. This cash dividend is payable on January 30, 2026 to shareholders of record as of December 29, 2025. A press release announcing the dividend is set forth in Exhibit 99.1 of this report.

 

Item 9.01Financial Statements and Exhibits.

 

EXHIBIT NO.DESCRIPTION
  
99.1Press release, dated December 18, 2025, issued by AMCON Distributing Company.
  
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AMCON DISTRIBUTING COMPANY
  (Registrant)
   
Date: December 18, 2025   /s/ Charles J. Schmaderer
  Name: Charles J. Schmaderer
  Title: Vice President, Chief Financial Officer and Secretary

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Amcon Distributing Co (DIT)

Reference

Frequently asked questions

When did Amcon Distributing Co file this 8-K?
Amcon Distributing Co (DIT) filed this Current Report (Form 8-K) with the SEC on December 18, 2025. The accession number assigned by EDGAR is 0001104659-25-122557.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Six directors elected; board declared a $0.28 per share special dividend payable January 30, 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Amcon Distributing Co's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Amcon Distributing Co has filed under CIK 928465, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer